Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589095 · ClinicalTrials.gov registry record
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT00589095 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 5 participants.
The verdict
NCT00589095 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether dynamic contrast enhanced MRI (DCE MRI) and high diffusion weighting MRI may be used to distinguish between favorable and unfavorable responses to therapy of glioblastoma multiforme. Imaging data will be correlated with histopathologic findings and clinical responses to radiation therapy with or without chemotherapy.
Interventions
- OTHER dynamic contrast enhanced magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-11 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589095
The ClinicalTrials.gov registry entry for NCT00589095 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dynamic contrast enhanced magnetic resonance imaging is the first listed.
NCT00589095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589095 about?
NCT00589095 is a clinical study titled "Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities". The purpose of this study is to determine whether dynamic contrast enhanced MRI (DCE MRI) and high diffusion weighting MRI may be used to distinguish between favorable and unfavorable responses to therapy of glioblastoma multiforme. Imaging data will be correlated with histopathologic findings and c...
What is the current status of trial NCT00589095?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2006-11. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00589095?
The interventions under investigation include: dynamic contrast enhanced magnetic resonance imaging (OTHER).
Who is sponsoring clinical trial NCT00589095?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.